X0609 4 2026-04-02 0000887359 Vericel Corp VCEL 0001626325 Hopper Jonathan Mark false 64 SIDNEY STREET CAMBRIDGE MA 02139 true Chief Medical Officer true Common Stock 2026-04-02 4 M 0 3472 10.95 A 79028 D Common Stock 2026-04-02 4 S 0 3472 35 D 75556 D Stock Option (Right to Buy) 10.95 2026-04-02 4 M 0 3472 0 A 2028-08-20 Common Stock 3472 9132 D These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 30, 2025. These options, representing the right to purchase 135,000 shares, became exercisable on August 20, 2019, the first anniversary of the date of grant, with 25% vesting and the remaining 75% vesting in equal quarterly installments over three years thereafter, contingent upon continued service to the Company. /s/ Sean Flynn, as Attorney-in-Fact for Jonathan Hopper 2026-04-06